skip to main content

DMARD monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMusculoskeletal TherapeuticsDMARD monitoringGPhC CRA

A patient taking sulfasalazine for rheumatoid arthritis requests a repeat supply. They have not had blood tests for four months and report unexplained bruising. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Arrange urgent FBC and prescriber review before further routine supply

Sulfasalazine can cause blood dyscrasias and requires blood monitoring, including FBC and liver function according to protocol. Unexplained bruising may suggest thrombocytopenia or other haematological toxicity. The lack of recent monitoring should be addressed before routine continuation. Peak flow and INR are not the key tests.

Reference: https://www.pharmacyregulation.org/students-and-trainees/pharmacist-education-and-training/registration-assessment